Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Nerman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lifetime Data Analysis|July 17, 1999
A parametric estimation procedure for relapse time distributionsL Ahlström, M Olsson, O Nerman
Journal of Neurology|November 22, 2017
A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and IcelandOlöf Eliasdottir, Anders Hildeman, Marco Longfils, et al.
Genomics|June 21, 2001
Rat-mouse and rat-human comparative maps based on gene homology and high-resolution zoo-FISHS Nilsson, K Helou, A Walentinsson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2022
Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohortB Skoog, J Link, H Tedeholm, et al.
Acta Neurologica Scandinavica|July 26, 2017
Diffusion tensor imaging in multiple sclerosis at different final outcomesO Andersen, A Hildeman, M Longfils, et al.
Tissue Antigens|December 1, 2000
The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disordersA T Naluai, S Nilsson, L Samuelsson, et al.
European Journal of Human Genetics : EJHG|February 13, 2002
Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11A T Naluai, S Nilsson, A H Gudjónsdóttir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lifetime Data Analysis|July 17, 1999
A parametric estimation procedure for relapse time distributionsL Ahlström, M Olsson, O Nerman
Journal of Neurology|November 22, 2017
A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and IcelandOlöf Eliasdottir, Anders Hildeman, Marco Longfils, et al.
Genomics|June 21, 2001
Rat-mouse and rat-human comparative maps based on gene homology and high-resolution zoo-FISHS Nilsson, K Helou, A Walentinsson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2022
Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohortB Skoog, J Link, H Tedeholm, et al.
Acta Neurologica Scandinavica|July 26, 2017
Diffusion tensor imaging in multiple sclerosis at different final outcomesO Andersen, A Hildeman, M Longfils, et al.
Tissue Antigens|December 1, 2000
The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disordersA T Naluai, S Nilsson, L Samuelsson, et al.
European Journal of Human Genetics : EJHG|February 13, 2002
Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11A T Naluai, S Nilsson, A H Gudjónsdóttir, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2012
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugsH Tedeholm, J Lycke, B Skoog, et al.
Pageof 1